Previous 10 | Next 10 |
BRIDGEWATER, N.J., March 20, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today provi...
IDEAYA Biosciences (NASDAQ: IDYA ) initiated with Buy rating and $12 (192% upside) price target at Roth Capital. More news on: IDEAYA Biosciences, Inc., Menlo Therapeutics Inc., Amarin Corporation plc, Healthcare stocks news, Stocks on the move, , Read more ...
Menlo Therapeutics (NASDAQ: MNLO ): FY GAAP EPS of -$1.66 beats by $0.56 . More news on: Menlo Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Foamix Became a Wholly Owned Subsidiary of Menlo Therapeutics Upon Closing of Merger on March 9, 2020 Menlo Conference Call and Webcast Scheduled for Thursday, March 12 at 8:30am Eastern Time BRIDGEWATER, N.J., March 12, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasd...
Menlo Therapeutics (NASDAQ: MNLO ) initiated with Buy rating and $8 (113% upside) price target at Bank of America. More news on: Menlo Therapeutics Inc., Nutrien Ltd., Apellis Pharmaceuticals, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
Merger activity increased last week with four new deals announced and two deals closing. Out of the four deals announced, three were cash deals and one was an all-stock deal. The acquisition of Forty Seven ([[FTSV]]) by Gilead Sciences ([[GILD]]) was the first deal announced last week. FTSV ...
Can These Penny Stocks Keep Heading Higher? Unless you’ve lived under a rock for the last few months, coronavirus is one of the top headline topics of the year. In fact, some of the highest traffic we’ve seen has come over the last month with a major focus on coronavirus penny s...
Thinly traded micro cap Menlo Therapeutics ( MNLO +20% ) is one of the few issues in the green today, up on more than triple normal volume, ahead of the expected March 9 close of its previously announced merger with Foamix Pharmaceuticals ( FOMX +3.2% ) after which the latter will be a...
Gainers: Digirad DRAD +122% . More news on: Tocagen Inc., Menlo Therapeutics Inc., ObsEva SA, Stocks on the move, , Read more ...
SELLAS Life Sciences Announces Positive Readout for Leukemia Drug SELLAS Life Sciences' ( SLS ) stock shot up as the company reported positive results from its Phase 1/2 study of its Galinpepimut-S treatment for patients with acute myeloid leukemia. The trial demonstrated that the patients...
News, Short Squeeze, Breakout and More Instantly...
BRIDGEWATER, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the upcoming H.C. Wainwright 22 nd Annual Global Investment Confe...
BRIDGEWATER, N.J. , Sept. 8, 2020 /PRNewswire/ -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today completed its previously announced corporate name change from Menlo Therapeutics Inc. to VYNE Therapeutics Inc. and the change of its ticker symbol from "MNLO" to "...
Company will commence trading under new ticker “VYNE” on September 8, 2020 Company to ring Nasdaq Closing Bell on September 8 BRIDGEWATER, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”...